Key Insights

Highlights

Success Rate

92% trial completion (above average)

Research Maturity

56 completed trials (57% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.1%

5 terminated out of 98 trials

Success Rate

91.8%

+5.3% vs benchmark

Late-Stage Pipeline

4%

4 trials in Phase 3/4

Results Transparency

14%

8 of 56 completed with results

Key Signals

8 with results92% success

Data Visualizations

Phase Distribution

76Total
Not Applicable (66)
P 1 (2)
P 2 (4)
P 3 (2)
P 4 (2)

Trial Status

Completed56
Unknown15
Recruiting13
Terminated5
Enrolling By Invitation4
Not Yet Recruiting3

Trial Success Rate

91.8%

Benchmark: 86.5%

Based on 56 completed trials

Clinical Trials (98)

Showing 20 of 20 trials
NCT05753774Phase 3TerminatedPrimary

Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders

NCT06197334Not ApplicableRecruiting

Gastro-intestinal Biopotential Recorder by Means of Surface ELEctrodes

NCT06904872Phase 2Recruiting

Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)

NCT07624656Not ApplicableNot Yet RecruitingPrimary

Functionally Enhanced Limosilactobacillus Reuteri Probiotic Preparation in Elderly Patients With Functional Bowel Disorders

NCT05501028Enrolling By InvitationPrimary

NLP to Aid in the Evaluation and Diagnosis of FGIDs

NCT05810168Not ApplicableCompleted

Traditional Dietary Advice Versus Low FODMAP Diet in Postprandial Functional Dyspepsia

NCT03823742Not ApplicableCompleted

Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?

NCT03369353Enrolling By Invitation

Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)

NCT04773158Not ApplicableCompletedPrimary

Systematic Pediatric Assessment of Rome Criteria (SPARC)

NCT06529913Not ApplicableRecruiting

Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases

NCT05212129Not ApplicableRecruitingPrimary

Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome

NCT05880199Recruiting

BSGM to Evaluate Patients With GI Symptoms

NCT06618677Not ApplicableCompleted

Efficacy of a Low FODMAP Diet in IBS Children and Impact on Urinary and Faecal Metabolome

NCT06653647Not ApplicableCompleted

Efficacy of Guided Imagery Therapy Mobile Application for Functional Abdominal Pain

NCT03460613Not ApplicableCompletedPrimary

Prevalence of FODMAP Intolerance and JHS in FGID and Association With Microbiome, Dyssynergic Defecation and Dietary Intervention

NCT03675321Not ApplicableCompletedPrimary

Defining Adolescent Nausea Through Brain Imaging and Neurostimulation Response

NCT05295446Enrolling By InvitationPrimary

Functional GI Disease Registry

NCT07089498Not ApplicableCompletedPrimary

13C-Octanoic Acid Breath Test on Gastric Emptying in Celiac Patients With Functional Disorders

NCT07086157Not ApplicableCompleted

Low-FODMAP Diet and Probiotics: Effects on Gut, Behavior, and Microbiota in Children With Autism Spectrum Disorder

NCT01495806Phase 4CompletedPrimary

Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood

Scroll to load more

Research Network

Activity Timeline